Investment Rating - The report gives an "Overweight" rating for the agricultural industry, indicating that it is expected to outperform the overall market [3][10]. Core Insights - The 2026 Central Document emphasizes food security and agricultural modernization, reiterating the importance of "new agricultural productivity" and the continuous focus on seed industry revitalization, particularly in biological breeding [4]. - In livestock, there is a shift towards "strengthening" comprehensive regulation of pig production capacity, with a focus on stabilizing the beef and dairy industries, and promoting dairy product consumption [4]. - The document highlights the importance of grain security, aiming to stabilize grain production at around 14 trillion jin, and introduces measures to enhance grain circulation efficiency [4]. - The report outlines the implementation of agricultural technology, including the integration of artificial intelligence with agriculture, and identifies key application scenarios such as drones, IoT, and robotics [4]. - The report suggests three main investment focuses: the recovery of the beef and dairy industries, the expected rebound in the pig cycle, and the continued advancement of the seed industry and biological breeding [4]. Summary by Sections Livestock Industry - The report indicates a comprehensive approach to regulating pig production capacity and acknowledges the success of measures taken to support the beef and dairy industries [4]. - It also mentions the introduction of multiple measures to promote dairy product consumption for the first time [4]. Crop Production - The focus remains on food security, with a commitment to stabilize grain production and enhance the efficiency of grain circulation [4]. - The report introduces a new round of initiatives aimed at increasing grain production capacity, particularly for oilseed crops like soybeans [4]. Seed Industry - The report emphasizes the ongoing implementation of seed industry revitalization actions and the acceleration of biological breeding industrialization [4]. - It notes the continuous mention of biological breeding in the Central Document over the past six years, highlighting its growing importance [4]. Agricultural Technology - The report outlines the path for implementing new agricultural productivity, emphasizing the need for technology integration, particularly in AI applications [4]. Agricultural Trade - The report advocates for the coordination of agricultural trade and production, promoting diversification of agricultural imports and supporting the export of competitive agricultural products [4].

智通财经APP讯，回盛生物(300871.SZ)披露2026年员工持股计划(草案)，参与对象总人数不超过14人， 拟筹集资金总额不超过人民币308.10万元，以"份"作为认购单位，每份份额为1.00元，员工持股计划的 份数上限为308.10万份。 员工持股计划股票来源为公司回购专用证券账户回购的回盛生物A股普通股股票。本计划经公司股东会 审议通过后，将通过非交易过户等法律法规允许的方式受让公司回购专用证券账户所持有的公司股份。 员工持股计划受让的股份总数不超过20.54万股，占员工持股计划草案公告日公司股本总额的0.10%。 ...

证券之星消息，2月4日动物保健板块较上一交易日下跌0.95%，生物股份领跌。当日上证指数报收于 4102.2，上涨0.85%。深证成指报收于14156.27，上涨0.21%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 920729 | 永顺生物 | 9.55 | 1.27% | 4.24万 | liv 4027.15万 | | 600195 | 中牧股份 | 8.00 | 1.14% | 13.94万 | + 1.11亿 | | 002688 | 金河生物 | 6.34 | 0.79% | 11.27万 | 7097.96万 | | 603566 | 普莱柯 | 14.09 | 0.64% | - 4.93万 | 6949.39万 | | 688526 | 科前生物 | 16.25 | 0.43% | 2.17万 | 3506.75万 | | 300119 | 瑞普生物 | 19.20 | 0.21% | 3.59万 | 6867.04万 | | 002141 ...

Core Viewpoint - The animal health sector experienced a rise of 1.15% on February 3, with *ST Green康 leading the gains, while the overall market indices also showed positive performance [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 4067.74, up by 1.29% [1]. - The Shenzhen Component Index closed at 14127.1, up by 2.19% [1]. Group 2: Individual Stock Performance - *ST Green康 (002868) closed at 36.70, with a gain of 3.29% and a trading volume of 11,000 lots, amounting to 39.61 million yuan [1]. - 回盛生物 (300871) closed at 28.30, up by 2.83%, with a trading volume of 166,400 lots and a turnover of 467 million yuan [1]. - 大禹生物 (920970) closed at 8.14, increasing by 2.13%, with a trading volume of 23,300 lots and a turnover of 18.92 million yuan [1]. - 普莱柯 (603566) closed at 14.00, up by 2.04%, with a trading volume of 66,100 lots and a turnover of 91.87 million yuan [1]. - 驱动力 (920275) closed at 9.15, increasing by 1.78%, with a trading volume of 14,900 lots and a turnover of 13.61 million yuan [1]. - 永顺生物 (920729) closed at 9.43, up by 1.73%, with a trading volume of 52,100 lots and a turnover of 48.48 million yuan [1]. - 科前生物 (688526) closed at 16.18, increasing by 1.25%, with a trading volume of 29,000 lots and a turnover of 46.60 million yuan [1]. - 申联生物 (688098) closed at 9.45, up by 0.96%, with a trading volume of 29,700 lots and a turnover of 27.90 million yuan [1]. - 生物股份 (600201) closed at 16.42, increasing by 0.86%, with a trading volume of 400,700 lots and a turnover of 655 million yuan [1]. - 瑞普生物 (300119) closed at 19.16, up by 0.63%, with a trading volume of 60,400 lots and a turnover of 115 million yuan [1]. Group 3: Capital Flow - The animal health sector saw a net outflow of 155 million yuan from institutional investors, while retail investors contributed a net inflow of 119 million yuan [2]. - The main capital flow data indicates that 中牧股份 (600195) had a net inflow of 5.91 million yuan from institutional investors [3]. - 普莱柯 (603566) experienced a net inflow of 5.90 million yuan from institutional investors, while retail investors had a net outflow of 12.09 million yuan [3]. - *ST Green康 (002868) had a net inflow of 2.82 million yuan from institutional investors, with retail investors contributing a net inflow of 2.25 million yuan [3].

Investment Rating - The industry investment rating is maintained as "Recommended" [1] Core Insights - The report highlights a continuous decline in pig prices while chick prices have seen an increase [2] - The Consumer Price Index (CPI) for December 2025 shows a year-on-year increase of 16% [2] - The report indicates significant price fluctuations in various agricultural products, with specific attention to the livestock sector [2][29] Summary by Sections Industry Overview - The agricultural sector, particularly livestock, is experiencing varied price movements, with pig prices at 12.25 yuan/kg, down 4.97% [29] - Chick prices have increased to 3.88 yuan/500g, reflecting a rise of 2.92% [29] Price Trends - The report notes a 11.54% increase in chick prices, indicating a potential shift in market dynamics [29] - The report also provides a detailed analysis of price changes in grains and oils, with domestic corn priced at 2271.43 yuan/ton, showing a 0.25% increase [22] Valuation Levels - As of January 30, 2026, the TTM (Trailing Twelve Months) P/E ratio for the industry is reported at 21.52, indicating a valuation perspective [18] - The report compares the agricultural sector's valuation against historical averages, suggesting potential investment opportunities [19] Important Announcements - The report includes significant announcements related to price changes and market conditions, emphasizing the importance of monitoring these trends for investment decisions [20]

证券之星消息，2月2日动物保健板块较上一交易日下跌4.9%，生物股份领跌。当日上证指数报收于 4015.75，下跌2.48%。深证成指报收于13824.35，下跌2.69%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 002141 | 后丰控股 | 3.98 | 0.76% | 29.51万 | 1.16亿 | | 002868 | *ST绿康 | 35.53 | -0.73% | 1.21万 | 4321.94万 | | 603566 | 普莱柯 | 13.72 | -1.15% | 7.48万 | 1.03亿 | | 688098 | 申联生物 | 9.36 | -1.78% | 4.23万 | 4019.07万 | | 688526 | 科前生物 | 15.98 | -3.33% | 4.70万 | 7617.62万 | | 600195 | 中牧股份 | 7.88 | -3.55% | 24.23万 | 1.95亿 | | 002688 | 金河生物 | ...

Core Viewpoint - The company expects a significant decline in net profit for the year 2025, projecting a decrease of over 50% compared to the previous year, despite positive sales growth in its veterinary pharmaceutical segment and increased revenue from its environmental services division [1][2]. Group 1: Performance Forecast - The performance forecast period is from January 1, 2025, to December 31, 2025 [1]. - The company anticipates a positive net profit but with a decline exceeding 50% [1]. Group 2: Sales and Revenue Drivers - The veterinary pharmaceutical segment continues to perform well, with increased sales in both domestic and international markets, particularly for the product "金霉素" [2]. - The completion of the company's sixth-phase project has led to increased production capacity, meeting market demand and generating additional profits [2]. - The environmental services segment has also seen a rise in revenue, contributing significantly to overall performance [2]. Group 3: Goodwill Impairment - The company plans to recognize a goodwill impairment of approximately 174.99 million yuan related to the acquisition of 金河佑本 (Jilin) Biotechnology Co., Ltd., which will reduce the net profit attributable to shareholders by about 149.81 million yuan for the year 2025 [2].

Group 1 - The core viewpoint of the article is that Jinhe Biological has announced a significant decline in its expected net profit for the fiscal year 2025, projecting a range of 30 million to 42 million yuan compared to 100.20 million yuan in the same period last year [2] Group 2 - The expected net profit for 2025 is estimated to be between 30 million and 42 million yuan [2] - The previous year's net profit was reported at 100.20 million yuan [2]

Investment Rating - The report maintains an "Overweight" rating for the agriculture, forestry, animal husbandry, and fishery industry [1][41]. Core Insights - The SW agriculture, forestry, animal husbandry, and fishery industry slightly underperformed the CSI 300 index, with a decline of 0.07% from January 16 to January 29, 2026, lagging behind the index by approximately 0.12 percentage points [3][10]. - Most sub-sectors recorded positive returns during the same period, with notable increases in planting (9.25%), animal health (4.71%), agricultural product processing (4.12%), and fishery (1.82%), while feed and breeding sectors saw declines of 0.02% and 2.84%, respectively [3][13][14]. - The overall price-to-book (PB) ratio for the industry was approximately 2.66 times as of January 29, 2026, indicating that the industry is at a relatively low valuation level compared to historical averages, positioned at about 59.9% of the valuation center since 2006 [3][18]. Industry Key Data - **Pig Farming**: - The average price of external three yuan pigs fluctuated from 12.76 CNY/kg to 13.24 CNY/kg before dropping to 12.52 CNY/kg during the reporting period [3][22]. - The breeding sow inventory reached 39.61 million heads by the end of December 2025, a decrease of 0.73% from the previous month, remaining within the normal range of 39 million heads [3][22]. - The profit from self-bred pigs was 25.1 CNY/head, while the profit from purchased piglets was 124.13 CNY/head, both maintaining positive profitability [3][26]. - **Poultry Farming**: - The average price of broiler chicks was 2.31 CNY/chick, showing a slight decrease, while the average price for layer chicks was 3.2 CNY/chick, which saw a minor increase [3][28]. - The average price for white feather broilers was 7.74 CNY/kg, with a profit of 0.39 CNY/chick, indicating a recovery in profitability [3][32]. - **Aquaculture**: - The average wholesale price for crucian carp and carp was stable, with prices at 19.4 CNY/kg and 13.88 CNY/kg, respectively, showing slight increases [3][33]. Industry Important News - The Ministry of Agriculture and Rural Affairs held a meeting to discuss stabilizing beef production and alleviating dairy industry challenges, emphasizing the need for effective policies to support these sectors [3][35]. - A meeting was also held to coordinate efforts in the seed industry revitalization action, focusing on enhancing domestic seed security and promoting technological independence [3][38]. Company Highlights - Key companies to watch include: - Muyuan Foods (牧原股份, 002714): A leading player in pig farming with cost and scale advantages [3][42]. - Haida Group (海大集团, 002311): A leading feed company expected to maintain steady market share growth [3][42]. - Shengnong Development (圣农发展, 002299): A leader in the white feather broiler industry with advantages in seed sources [3][42]. - Reap Bio (瑞普生物, 300119): A leader in the animal health sector with a growing product matrix for pet health [3][42]. - Longping High-Tech (隆平高科, 000998): A leading seed company with advanced transgenic reserves [3][42].

Core Viewpoint - The animal health sector experienced a slight decline of 0.23% on January 30, with Jinhe Biological leading the drop. The Shanghai Composite Index closed at 4117.95, down 0.96%, while the Shenzhen Component Index closed at 14205.89, down 0.66% [1]. Group 1: Stock Performance - The closing prices and performance of key stocks in the animal health sector showed varied results, with Huisheng Biological rising by 3.51% to 29.46, while Jinhe Biological fell by 2.98% to 6.51 [1][2]. - The trading volume for Huisheng Biological was 303,100 shares, with a transaction value of 901 million yuan, indicating strong market interest [1]. Group 2: Capital Flow - The animal health sector saw a net inflow of 59.82 million yuan from institutional investors, while retail investors experienced a net outflow of 81.83 million yuan, indicating a shift in investor sentiment [2][3]. - Among individual stocks, Huisheng Biological attracted a significant net inflow of 1.23 billion yuan from institutional investors, while Jinhe Biological faced a net outflow of 543.32 million yuan [3].